1-3 of 3
Gissou Azabdaftari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B13: Regulation of Akt activity, cell proliferation, and viability in ovarian cancer cells by calcium/calmodulin-dependent protein kinase kinase 2

Angela M. Gocher, Thomas F. Franke, Gissou Azabdaftari, Loukia G. Karacosta, Arthur M. Edelman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): B13.
https://doi.org/10.1158/1538-8514.PI3K14-B13
Published: 06 July 2015
View article titled, Abstract B13: Regulation of Akt activity, cell proliferation, and viability in ovarian cancer cells by calcium/calmodulin-dependent protein kinase kinase 2
Journal Articles

Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma

Leigh Ellis, Preeti Shah, Hans Hammers, Kristin Lehet, Paula Sotomayor, Gissou Azabdaftari, Mukund Seshadri, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 383–392.
https://doi.org/10.1158/1535-7163.MCT-11-0748
Published: 08 February 2012
View article titled, Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma
Open the PDF for Vascular Disruption in Combination with mTOR Inhibition in Renal Cell Carcinoma in another window
Journal Articles

Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer

Anika Agarwal, Lidija Covic, Leila M. Sevigny, Nicole C. Kaneider, Katherine Lazarides, Gissou Azabdaftari, Sheida Sharifi, Athan Kuliopulos
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (9): 2746–2757.
https://doi.org/10.1158/1535-7163.MCT-08-0177
Published: 11 September 2008
View article titled, Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Open the PDF for Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer in another window
Includes: Supplementary data